These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18706399)

  • 21. [Bisphosphonates and adhesion molecules].
    Takeyama S; Shinoda H
    Clin Calcium; 2002 May; 12(5):627-30. PubMed ID: 15775348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of orotidylic acid pyrophosphorylase in Saccharomyces cerevisiae.
    Jund R; Lacroute F
    J Bacteriol; 1972 Jan; 109(1):196-202. PubMed ID: 4550660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis of mapping the spontaneous mutations with 5-flurouracil in uracil phosphoribosyltransferase from Mycobacterium tuberculosis.
    Ghode P; Jobichen C; Ramachandran S; Bifani P; Sivaraman J
    Biochem Biophys Res Commun; 2015 Nov; 467(3):577-82. PubMed ID: 26456658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bisphosphonates and osteonecrosis of the jaw].
    Saussez S; Filleul O; Loeb I
    Rev Stomatol Chir Maxillofac; 2008 Dec; 109(6):367-73. PubMed ID: 19013624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
    Kyrgidis A; Triaridis S; Vahtsevanos K; Antoniades K
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of pyrophosphate correlates with the increased level of nucleoside triphosphates in Escherichia coli.
    Kukko E; Kallio T
    Biochem Int; 1984 Jan; 8(1):1-7. PubMed ID: 6089813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonates and dental implants: current problems.
    Flichy-Fernández AJ; Balaguer-Martínez J; Peñarrocha-Diago M; Bagán JV
    Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E355-60. PubMed ID: 19561566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The uptake characteristics of 5-fluorouracil in the Caco-2 model system].
    Chen J; Xu Z; Li Y
    Yao Xue Xue Bao; 1998; 33(3):222-5. PubMed ID: 11938968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods.
    Zacharis CK; Tzanavaras PD
    J Pharm Biomed Anal; 2008 Nov; 48(3):483-96. PubMed ID: 18599247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation pathways of 5-fluorouracil in rat organs and in PC12 cells.
    Mascia L; Ipata PL
    Biochem Pharmacol; 2001 Jul; 62(2):213-8. PubMed ID: 11389880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
    Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
    Fukunaga M
    Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baker's yeast UMP:pyrophosphate phosphoribosyltransferase. Purification, enzymatic and kinetic properties.
    Natalini P; Ruggieri S; Santarelli I; Vita A; Magni G
    J Biol Chem; 1979 Mar; 254(5):1558-63. PubMed ID: 216696
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials.
    Machado M; Cruz LS; Tannus G; Fonseca M
    Clin Ther; 2009 May; 31(5):962-79. PubMed ID: 19539097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alendronate augments interleukin-1beta release from macrophages infected with periodontal pathogenic bacteria through activation of caspase-1.
    Deng X; Tamai R; Endo Y; Kiyoura Y
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):97-104. PubMed ID: 19063908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bone fracture and the healing mechanisms. The effects of anti-resorptive agents on fracture healing].
    Mashiba T; Mori S
    Clin Calcium; 2009 May; 19(5):673-9. PubMed ID: 19398835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uracil salvage is necessary for early Arabidopsis development.
    Mainguet SE; Gakière B; Majira A; Pelletier S; Bringel F; Guérard F; Caboche M; Berthomé R; Renou JP
    Plant J; 2009 Oct; 60(2):280-91. PubMed ID: 19563437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New development in bisphosphonate treatment. Treatment with bisphosphonates for cancer-induced bone disease].
    Abe M
    Clin Calcium; 2009 Jan; 19(1):55-62. PubMed ID: 19122265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
    Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.